Macrogol Generis (Macrogol 4000)

Macrogol 4000 is a high‑molecular-weight polyethylene glycol that is minimally absorbed. It creates an osmotic gradient that draws water into the intestinal tract, increasing stool volume and softness. The added bulk stimulates peristaltic activity, facilitating the passage of stool through the colon.

The dosage of Macrogol Generis is individualized by the prescribing healthcare professional based on the patient’s age, severity of constipation, and clinical response. The prescriber determines the appropriate amount, frequency, and duration of therapy, and patients should follow the written instructions on the prescription label.

Safety data for macrogol 4000 in pregnancy and lactation are limited. Healthcare providers generally recommend using the product only if the potential benefit outweighs any possible risk to the fetus or infant. Pregnant or nursing women should discuss use with their physician before starting treatment.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, macrogol 4000 acts osmotically, softening stool without stimulating intestinal nerves, which often results in fewer cramping side effects. Unlike saline laxatives, it is not absorbed systemically, reducing the risk of electrolyte disturbances when used as directed. Choice of therapy depends on patient needs and clinician judgment.

Macrogol Generis should be stored at ambient temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

The product is taken orally, usually dissolved in a measured amount of water or another suitable liquid as directed by the prescriber. It can be consumed with or without food, but patients should follow the specific preparation instructions provided on the label or by their healthcare professional.

The most serious risks include severe dehydration, electrolyte imbalances such as low sodium or potassium, and rare allergic reactions that may present as rash, swelling or breathing difficulty. Patients experiencing these symptoms should seek immediate medical attention.

Macrogol Generis is contraindicated in individuals with known hypersensitivity to macrogol or polyethylene glycol, in patients with intestinal obstruction, perforation, or severe inflammatory bowel disease, and in those for whom laxative therapy is medically inappropriate. Clinicians should evaluate each patient’s medical history before prescribing.